Koninklijke Philips (PHG) Return on Capital Employed (2009 - 2026)

Koninklijke Philips (PHG) recorded quarterly Return on Capital Employed of 10.45% in Q1 2026, up 2.5% quarter-over-quarter from 10.19% in Q4 2025, and up 328.0% on a YoY basis from 2.44% in Q1 2025.

Koninklijke Philips (PHG) Return on Capital Employed (2009 - 2026) Analysis & Trends

Koninklijke Philips' Return on Capital Employed history runs 9 years deep, the most recent figure standing at 10.45% for Q1 2026.

  • In Q1 2026, Return on Capital Employed rose 328.0% year-over-year to 10.45%; the TTM figure through Mar 2026 stood at 10.45% (up 328.0% YoY), while the FY2025 annual figure was 7.39%, up 489.0% from the prior year.
  • Return on Capital Employed was 10.45% for Q1 2026 at Koninklijke Philips, up from 10.19% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 10.45% in Q1 2026 to a low of 5.69% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 9.61%
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 12.24%
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 7.36%
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 9.62%
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 11.13%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 10.45%
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 24.24%
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 9.30%
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 11.57%
10 Zimmer Biomet Holdings 17.18 Bn 16.77 Bn 1.51 Bn 5.88%

Historic Data

Download Data
DateValue
Mar 31, 2026 10.45%
Dec 31, 2025 10.19%
Sep 30, 2025 8.42%
Jun 30, 2025 5.69%
Mar 31, 2025 7.17%
Dec 31, 2017 6.92%
Sep 30, 2017 -3,797,659.91%
Jun 30, 2017 -3,834,913.75%
Mar 31, 2017 -3,480,017.13%
Dec 31, 2016 -3,567,638.32%
Sep 30, 2016 10.29%
Jun 30, 2016 8.55%
Mar 31, 2016 8.81%
Dec 31, 2015 8.80%
Sep 30, 2015 6.60%
Jun 30, 2015 9.18%
Mar 31, 2015 9.42%
Dec 31, 2014 11.46%
Jun 30, 2013 13.51%
Mar 31, 2013 12.11%